Related Experiment Videos
Postnatal development of proteins irreversibly labeled by [3H]flunitrazepam
Neuroscience Letters
|July 20, 1982
Summary
[3H]flunitrazepam binding in rat hippocampus reveals distinct protein labeling patterns postnatally. Early labeling favors P55 and P59 proteins, with P51 protein labeling increasing in the second week, suggesting developmental changes in benzodiazepine receptor subtypes.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Benzodiazepine receptors are crucial for neuronal inhibition.
- Understanding the developmental expression of these receptors is vital.
- Flunitrazepam is a commonly used benzodiazepine ligand for receptor studies.
Purpose of the Study:
- To investigate the developmental changes in protein labeling by [3H]flunitrazepam in the rat hippocampus.
- To identify specific proteins associated with benzodiazepine receptors during early postnatal development.
Main Methods:
- Isolation of hippocampal membranes from rats at different postnatal timepoints.
- Irreversible labeling of proteins using the radioligand [3H]flunitrazepam.
- Analysis of protein molecular weights (P51, P55, P59) using gel electrophoresis.
Main Results:
- [3H]flunitrazepam predominantly labeled P55 and P59 proteins in the early postnatal days.
- Labeling of P51 protein significantly increased starting in the second postnatal week.
- Differential developmental expression of labeled proteins suggests distinct receptor populations.
Conclusions:
- The findings suggest a developmental shift in benzodiazepine receptor subunit expression in the rat hippocampus.
- P55 and P59 may be associated with type 2 benzodiazepine receptors, while P51 might be linked to type 1 receptors.
- These developmental changes are critical for understanding the maturation of inhibitory neurotransmission.